Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure.
CONCLUSION: These findings suggest that bosutinib therapy is associated with improved HRQoL in advanced phase CML patients.
CLINICAL TRIAL REGISTRATION: NCT00261846.
PMID: 27045164 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chronic Leukemia | Chronic Myeloid Leukaemia | Clinical Trials | Gleevec | Health | Leukemia | Research | Study